<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26110785</PMID><DateCompleted><Year>2016</Year><Month>04</Month><Day>22</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>6</Issue><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Selection and Characterization of DNA Aptamers Targeting All Four Serotypes of Dengue Viruses.</ArticleTitle><Pagination><StartPage>e0131240</StartPage><MedlinePgn>e0131240</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0131240</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0131240</ELocationID><Abstract><AbstractText>Dengue viruses (DENVs) are members of Flaviviridae family, which are associated with human disease. The envelope (E) protein plays an important role in viral infection. However, there is no effective antibody for clinical treatment due to antibody dependent enhancement of infection. In this study, using Systematic Evolution of Ligands by Exponential Enrichment (SELEX), we demonstrated the first aptamer (S15) that can bind to DENV-2 envelop protein domain III (ED3) with a high binding affinity. S15 was found to form a parallel quadruplex based on Quadfinder prediction, gel mobility assay and circular dichroism studies. Both the quadruplex structure and the sequence on 5'-end were necessary for the binding activity of S15. NMR titration experiments indicated that S15 bound to a highly conserved loop between &#x3b2;A and &#x3b2;B strands of ED3. Moreover, S15 can neutralize the infections by all four serotypes of DENVs. Our result provides a new opportunity in the development of DNA aptamers against DENVs in the future.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Heng-Li</ForeName><Initials>HL</Initials><AffiliationInfo><Affiliation>Institute of Biotechnology and Department of Life Science, National Tsing Hua University, Hsinchu 300, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsiao</LastName><ForeName>Wen-Hsin</ForeName><Initials>WH</Initials><AffiliationInfo><Affiliation>Institute of Biotechnology and Department of Life Science, National Tsing Hua University, Hsinchu 300, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Hsiang-Chi</ForeName><Initials>HC</Initials><AffiliationInfo><Affiliation>Institute of Biotechnology and Department of Life Science, National Tsing Hua University, Hsinchu 300, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Suh-Chin</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Institute of Biotechnology and Department of Life Science, National Tsing Hua University, Hsinchu 300, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Jya-Wei</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Institute of Biotechnology and Department of Life Science, National Tsing Hua University, Hsinchu 300, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>06</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D052157">Aptamers, Nucleotide</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004279">DNA, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014759">Viral Envelope Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019943" MajorTopicYN="N">Amino Acid Substitution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D052157" MajorTopicYN="N">Aptamers, Nucleotide</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004279" MajorTopicYN="N">DNA, Viral</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018604" MajorTopicYN="N">Epitope Mapping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054856" MajorTopicYN="N">G-Quadruplexes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016297" MajorTopicYN="N">Mutagenesis, Site-Directed</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009500" MajorTopicYN="N">Neutralization Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017434" MajorTopicYN="N">Protein Structure, Tertiary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D052156" MajorTopicYN="N">SELEX Aptamer Technique</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017386" MajorTopicYN="N">Sequence Homology, Amino Acid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065288" MajorTopicYN="N">Serogroup</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014759" MajorTopicYN="N">Viral Envelope Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing Interests: </b>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>2</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>5</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26110785</ArticleId><ArticleId IdType="pmc">PMC4482433</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0131240</ArticleId><ArticleId IdType="pii">PONE-D-15-06585</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Whitehead SS, Blaney JE, Durbin AP, Murphy BR. Prospects for a dengue virus vaccine. Nat Rev Microbiol. 2007;5(7):518&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">17558424</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn PC. The molecular basis of virulence of the encephalitogenic flaviviruses. J Gen Virol. 1997;78 (Pt 11):2711&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">9367356</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez IJ, Ruiz BH. A single nucleotide change in the E protein gene of dengue virus 2 Mexican strain affects neurovirulence in mice. J Gen Virol. 1996;77 (Pt 10):2541&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">8887488</ArticleId></ArticleIdList></Reference><Reference><Citation>Pokidysheva E, Zhang Y, Battisti AJ, Bator-Kelly CM, Chipman PR, Xiao C, et al. Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN. Cell. 2006;124(3):485&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">16469696</ArticleId></ArticleIdList></Reference><Reference><Citation>Rey FA, Heinz FX, Mandl C, Kunz C, Harrison SC. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature. 1995;375(6529):291&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">7753193</ArticleId></ArticleIdList></Reference><Reference><Citation>Modis Y, Ogata S, Clements D, Harrison SC. Structure of the dengue virus envelope protein after membrane fusion. Nature. 2004;427(6972):313&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">14737159</ArticleId></ArticleIdList></Reference><Reference><Citation>Modis Y, Ogata S, Clements D, Harrison SC. Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein. J Virol. 2005;79(2):1223&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC538574</ArticleId><ArticleId IdType="pubmed">15613349</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandl CW, Allison SL, Holzmann H, Meixner T, Heinz FX. Attenuation of tick-borne encephalitis virus by structure-based site-specific mutagenesis of a putative flavivirus receptor binding site. J Virol. 2000;74(20):9601&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC112392</ArticleId><ArticleId IdType="pubmed">11000232</ArticleId></ArticleIdList></Reference><Reference><Citation>Crill WD, Roehrig JT. Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J Virol. 2001;75(16):7769&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC115016</ArticleId><ArticleId IdType="pubmed">11462053</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu JJ, Rajamanonmani R, Li J, Bhuvanakantham R, Lescar J, Ng ML. Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein. J Gen Virol. 2005;86(Pt 2):405&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">15659760</ArticleId></ArticleIdList></Reference><Reference><Citation>Hrobowski YM, Garry RF, Michael SF. Peptide inhibitors of dengue virus and West Nile virus infectivity. Virol J. 2005;2:49</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1177995</ArticleId><ArticleId IdType="pubmed">15927084</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin JF, Chu JJ, Ng ML. The envelope glycoprotein domain III of dengue virus serotypes 1 and 2 inhibit virus entry. Microbes Infect. 2007;9(1):1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">17196419</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang ZS, Yan YS, Weng YW, Huang HL, Li SQ, He S, et al. High-level expression of recombinant dengue virus type 2 envelope domain III protein and induction of neutralizing antibodies in BALB/C mice. J Virol Methods. 2007;143(2):125&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">17532481</ArticleId></ArticleIdList></Reference><Reference><Citation>Alka, Bharati K, Malik YP, Vrati S. Immunogenicity and protective efficacy of the E. coli-expressed domain III of Japanese encephalitis virus envelope protein in mice. Med Microbiol Immunol. 2007;196(4):227&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">17377815</ArticleId></ArticleIdList></Reference><Reference><Citation>Martina BE, Koraka P, van den Doel P, van Amerongen G, Rimmelzwaan GF, Osterhaus AD. Immunization with West Nile virus envelope domain III protects mice against lethal infection with homologous and heterologous virus. Vaccine. 2008;26(2):153&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7127062</ArticleId><ArticleId IdType="pubmed">18069096</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim AC, Lin W, Tan GK, Sim MS, Chow VT, Alonso S. Induction of neutralizing antibodies against dengue virus type 2 upon mucosal administration of a recombinant Lactococcus lactis strain expressing envelope domain III antigen. Vaccine. 2008;26(9):1145&#x2013;54. 10.1016/j.vaccine.2007.12.047</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2007.12.047</ArticleId><ArticleId IdType="pubmed">18243432</ArticleId></ArticleIdList></Reference><Reference><Citation>Lok SM, Kostyuchenko V, Nybakken GE, Holdaway HA, Battisti AJ, Sukupolvi-Petty S, et al. Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins. Nat Struct Mol Biol. 2008;15(3):312&#x2013;7. 10.1038/nsmb.1382</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.1382</ArticleId><ArticleId IdType="pubmed">18264114</ArticleId></ArticleIdList></Reference><Reference><Citation>Raviprakash K, Wang D, Ewing D, Holman DH, Block K, Woraratanadharm J, et al. A tetravalent dengue vaccine based on a complex adenovirus vector provides significant protection in rhesus monkeys against all four serotypes of dengue virus. J Virol. 2008;82(14):6927&#x2013;34. 10.1128/JVI.02724-07</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02724-07</ArticleId><ArticleId IdType="pmc">PMC2446963</ArticleId><ArticleId IdType="pubmed">18480438</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB, O'Rourke EJ. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J Exp Med. 1977;146(1):201&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2180729</ArticleId><ArticleId IdType="pubmed">406347</ArticleId></ArticleIdList></Reference><Reference><Citation>Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev. 1998;11(3):480&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC88892</ArticleId><ArticleId IdType="pubmed">9665979</ArticleId></ArticleIdList></Reference><Reference><Citation>Rigau-Perez JG, Clark GG, Gubler DJ, Reiter P, Sanders EJ, Vorndam AV. Dengue and dengue haemorrhagic fever. Lancet. 1998;352(9132):971&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">9752834</ArticleId></ArticleIdList></Reference><Reference><Citation>Villar L, Dayan GH, Arredondo-Garcia JL, Rivera DM, Cunha R, Deseda C, et al. Efficacy of a tetravalent dengue vaccine in children in Latin America. N Engl J Med. 2015;372(2):113&#x2013;23. 10.1056/NEJMoa1411037</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1411037</ArticleId><ArticleId IdType="pubmed">25365753</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellington AD, Szostak JW. In vitro selection of RNA molecules that bind specific ligands. Nature. 1990;346(6287):818&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">1697402</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science. 1990;249(4968):505&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">2200121</ArticleId></ArticleIdList></Reference><Reference><Citation>Pileur F, Andreola ML, Dausse E, Michel J, Moreau S, Yamada H, et al. Selective inhibitory DNA aptamers of the human RNase H1. Nucleic Acids Res. 2003;31(19):5776&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC206449</ArticleId><ArticleId IdType="pubmed">14500841</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann D, Reinemann C, Stoltenburg R, Strehlitz B. In vitro selection of DNA aptamers binding ethanolamine. Biochem Biophys Res Commun. 2005;338(4):1928&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">16289104</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang J, Yu T, Guo L, Xie J, Shao N, He Z. In vitro selection of DNA aptamer against abrin toxin and aptamer-based abrin direct detection. Biosens Bioelectron. 2007;22(11):2456&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">17055241</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen F, Zhou J, Luo F, Mohammed AB, Zhang XL. Aptamer from whole-bacterium SELEX as new therapeutic reagent against virulent Mycobacterium tuberculosis. Biochem Biophys Res Commun. 2007;357(3):743&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">17442275</ArticleId></ArticleIdList></Reference><Reference><Citation>Shangguan D, Meng L, Cao ZC, Xiao Z, Fang X, Li Y, et al. Identification of liver cancer-specific aptamers using whole live cells. Anal Chem. 2008;80(3):721&#x2013;8. 10.1021/ac701962v</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ac701962v</ArticleId><ArticleId IdType="pubmed">18177018</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy MB, Fuller ST, Richardson PM, Doyle SA. An improved method for the in vitro evolution of aptamers and applications in protein detection and purification. Nucleic Acids Res. 2003;31(18):e110</Citation><ArticleIdList><ArticleId IdType="pmc">PMC203336</ArticleId><ArticleId IdType="pubmed">12954786</ArticleId></ArticleIdList></Reference><Reference><Citation>Gopinath SC. Methods developed for SELEX. Anal Bioanal Chem. 2007;387(1):171&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">17072603</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng XZ, Lin Z, Yang LJ, Wang C, Bai CI. Investigation of the interaction between acridine orange and bovine serum albumin. Talanta. 1998;47(5):1223&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">18967427</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang KC, Lee MC, Wu CW, Huang KJ, Lei HY, Cheng JW. Solution structure and neutralizing antibody binding studies of domain III of the dengue-2 virus envelope protein. Proteins. 2008;70(3):1116&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">18004779</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell PK, Nisalak A, Sukhavachana P, Vivona S. A plaque reduction test for dengue virus neutralizing antibodies. J Immunol. 1967;99(2):285&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">6031202</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer F, Sticht H. A proline to glycine mutation in the Lck SH3-domain affects conformational sampling and increases ligand binding affinity. FEBS Lett. 2007;581(8):1555&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">17382937</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J, Honda W. CED: a conformational epitope database. BMC Immunology. 2006;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1513601</ArticleId><ArticleId IdType="pubmed">16603068</ArticleId></ArticleIdList></Reference><Reference><Citation>Modis Y, Ogata S, Clements D, Harrison SC. A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci U S A. 2003;100(12):6986&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC165817</ArticleId><ArticleId IdType="pubmed">12759475</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikin O, D'Antonio L, Bagga PS. QGRS Mapper: a web-based server for predicting G-quadruplexes in nucleotide sequences. Nucleic Acids Res. 2006;34(Web Server issue):W676&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1538864</ArticleId><ArticleId IdType="pubmed">16845096</ArticleId></ArticleIdList></Reference><Reference><Citation>Sukupolvi-Petty S, Austin SK, Purtha WE, Oliphant T, Nybakken GE, Schlesinger JJ, et al. Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes. J Virol. 2007;81(23):12816&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2169112</ArticleId><ArticleId IdType="pubmed">17881453</ArticleId></ArticleIdList></Reference><Reference><Citation>Gromowski GD, Barrett ND, Barrett AD. Characterization of dengue virus complex-specific neutralizing epitopes on envelope protein domain III of dengue 2 virus. J Virol. 2008;82(17):8828&#x2013;37. 10.1128/JVI.00606-08</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00606-08</ArticleId><ArticleId IdType="pmc">PMC2519678</ArticleId><ArticleId IdType="pubmed">18562544</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsui K, Gromowski GD, Li L, Schuh AJ, Lee JC, Barrett AD. Characterization of dengue complex-reactive epitopes on dengue 3 virus envelope protein domain III. Virology. 2009;384(1):16&#x2013;20. 10.1016/j.virol.2008.11.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2008.11.013</ArticleId><ArticleId IdType="pubmed">19101005</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiel K. Oligo oligarchy-the surprisingly small world of aptamers. Nat Biotechnol. 2004;22(6):649&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">15175673</ArticleId></ArticleIdList></Reference><Reference><Citation>Balagurumoorthy P, Brahmachari SK, Mohanty D, Bansal M, Sasisekharan V. Hairpin and parallel quartet structures for telomeric sequences. Nucleic Acids Res. 1992;20(15):4061&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC334088</ArticleId><ArticleId IdType="pubmed">1508691</ArticleId></ArticleIdList></Reference><Reference><Citation>Phan AT, Kuryavyi V, Ma JB, Faure A, Andreola ML, Patel DJ. An interlocked dimeric parallel-stranded DNA quadruplex: a potent inhibitor of HIV-1 integrase. Proc Natl Acad Sci U S A. 2005;102(3):634&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC545538</ArticleId><ArticleId IdType="pubmed">15637158</ArticleId></ArticleIdList></Reference><Reference><Citation>Fialova M, Kypr J, Vorlickova M. The thrombin binding aptamer GGTTGGTGTGGTTGG forms a bimolecular guanine tetraplex. Biochem Biophys Res Commun. 2006;344(1):50&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">16616893</ArticleId></ArticleIdList></Reference><Reference><Citation>Rujan IN, Meleney JC, Bolton PH. Vertebrate telomere repeat DNAs favor external loop propeller quadruplex structures in the presence of high concentrations of potassium. Nucleic Acids Res. 2005;33(6):2022&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1074753</ArticleId><ArticleId IdType="pubmed">15817566</ArticleId></ArticleIdList></Reference><Reference><Citation>Michalowski D, Chitima-Matsiga R, Held DM, Burke DH. Novel bimodular DNA aptamers with guanosine quadruplexes inhibit phylogenetically diverse HIV-1 reverse transcriptases. Nucleic Acids Res. 2008;36(22):7124&#x2013;35. 10.1093/nar/gkn891</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkn891</ArticleId><ArticleId IdType="pmc">PMC2602765</ArticleId><ArticleId IdType="pubmed">18996899</ArticleId></ArticleIdList></Reference><Reference><Citation>Macaya RF, Schultze P, Smith FW, Roe JA, Feigon J. Thrombin-binding DNA aptamer forms a unimolecular quadruplex structure in solution. Proc Natl Acad Sci U S A. 1993;90(8):3745&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC46378</ArticleId><ArticleId IdType="pubmed">8475124</ArticleId></ArticleIdList></Reference><Reference><Citation>Mashima T, Matsugami A, Nishikawa F, Nishikawa S, Katahira M. Unique quadruplex structure and interaction of an RNA aptamer against bovine prion protein. Nucleic Acids Res. 2009;37(18):6249&#x2013;58. 10.1093/nar/gkp647</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkp647</ArticleId><ArticleId IdType="pmc">PMC2764455</ArticleId><ArticleId IdType="pubmed">19666719</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>